Pharmafile Logo
Pharmafocus logo
Advanced Search

Thought Leadership

Showing 15 posts of 91 posts found.

Is global consistency in GCP interpretation an achievable goal?

November 16, 2011
Research and Development

The potential benefits of standardisation in the conduct of an increasingly global clinical research effort are enormous. The promise of …

Feature
Thought Leadership

Quicker and slicker: new initiatives to improve clinical trial delivery

November 16, 2011
Research and Development

Faster study set-up times, reduced bureaucracy and timely patient recruitment – these things are central to the success of commercial …

Feature
Thought Leadership

Infectious diseases versus clinical researchers. Who is winning?

November 16, 2011
Research and Development

They were running hand in hand, and the Queen went so fast that it was all she could do to …

Feature
Thought Leadership

Full service CROs: a cost-effective option for global therapeutically focused clinical development expertise

November 16, 2011
Research and Development

Skyrocketing clinical development costs are bad news for everyone, from pharmaceutical companies to patients. That’s why it’s crucial we find …

Feature
Thought Leadership

Emerging markets: comparing India and China as the future R&D hubs for the pharmaceutical industry

November 16, 2011
Research and Development

The pharmaceutical industry is expanding worldwide. For the last few years, the emerging markets that offer the dynamics of growth …

Feature
Thought Leadership

Pharmacovigilance in the EU – recent and future changes

November 15, 2011
Research and Development

Changes to both post-marketing and clinical trial requirements

Feature
Thought Leadership

The roles and responsibilities of an EEA qualified person for pharmacovigilance (QPPV)

November 15, 2011
Research and Development

The roles and responsibilities of an EEA Qualified Person for Pharmacovigilance are based on the current Directive 2001/83/EC and Vol …

Feature
Thought Leadership

Medical meetings and events – how to make the most of your budget

November 14, 2011
Sales and Marketing

 In today’s uncertain economic climate, much like every other form of marketing and business expenditure, event budgets are under scrutiny …

Feature
Thought Leadership

Creatures of habit: the long road to behavioural change

November 14, 2011
Medical Communications

 Budget cycles versus strong foundations Medical education has traditionally been about setting strong foundations for your brand, either pre-launch or to …

Feature
Thought Leadership

Call for collaborative creativity

November 14, 2011
Medical Communications

Ever since clients started contracting work out to consultancies, marketing professionals on both sides of the arrangement have been seeking …

Feature
Thought Leadership

Engaging with the NHS – through patients?

November 14, 2011
Medical Communications

 Traditionally NHS joint working has been about pharma and the NHS working together in a collaborative and transparent fashion. These …

Feature
Thought Leadership

Understanding individual decision-making in health

November 14, 2011
Medical Communications

 Why now is the right time for pharma to get closer to patients and health consumers

Feature
Thought Leadership

Digital: Those who make an effort to adapt are the most likely to succeed

November 11, 2011
Sales and Marketing

Last year we spoke about digital marketing becoming an ‘immersive experience’ and the challenge that our clients face in responding …

Feature
Thought Leadership

Bagel Talk

November 11, 2011
Medical Communications

Has anyone noticed that it’s getting tougher out there these days?I am addicted to West Wing. I re-run the DVD …

Feature
Thought Leadership

The future started yesterday…

November 11, 2011
Medical Communications

Do you feel you’re ‘behind the curve’ on digital?  Trust me, we hear that a lot. Whether it’s friends or former …

Feature
Thought Leadership
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026